transforming proteins into pioneering drugs
Formulation Science
Protein drug formulation is particularly challenging due to structural complexity and instability. The biological activity of most recombinant proteins emanates specifically from their 3-dimensional structure which needs to remain unaltered throughout the shelf-life of the product. However, cleavage or aggregation incidents … [Read More...]
Analytics
State-of-the-art biopharmaceutical development relies on high-end protein analytics as a fundamental prerequisite to characterize protein drug substances, drug products and processes. We are at your disposal to implement your existing methods or will gladly develop methods tailored specifically to your project. Protein … [Read More...]
Pharmaceutical Process Development
Our pilot lab is equipped with all relevant process technologies which are also used in commercial aseptic manufacturing of drug products. During pharmaceutical process development we take specific characteristics of the formulation for fill-finish like viscosity, surface incompatibilities, shear sensitivity into account. … [Read More...]
Company News
Formulations for clinical trials and beyond
Budget is often scarce for pharmaceutical development projects before the drug has even shown proof of concept in first clinical trials. In that early stage, many drug developing companies are … [Read More...]
About Us
ProJect Pharmaceutics was founded and is managed by Andreas Schütz and Klaus Hellerbrand, two leading experts in protein formulation and pharmaceutical process development with many years of experience in bio-pharmaceutics.
Their combined expertise and complementary set of qualifications enables ProJect Pharmaceutics to deliver pharmaceutical... [Read More …]